Lagonero, Rhea May .
HRN: 13-27-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/02/2023
09/08/2023
PO
15ml
Q8H
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes